These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2124728)

  • 21. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.
    Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP
    J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-step PCR for the identification of multiple antimicrobial resistance in Neisseria gonorrhoeae.
    Lawung R; Cherdtrakulkiat R; Charoenwatanachokchai A; Nabu S; Suksaluk W; Prachayasittikul V
    J Microbiol Methods; 2009 Jun; 77(3):323-5. PubMed ID: 19341768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of chromosomally mediated antimicrobial resistance in Neisseria gonorrhoeae in Canada: 1994-1999.
    Ng LK; Martin I; Lau A;
    Sex Transm Dis; 2003 Dec; 30(12):896-900. PubMed ID: 14646637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
    Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance in Neisseria gonorrhoeae.
    Tapsall JW
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status of the antibiotic resistance of Neisseria gonorrhoeae].
    Lind I
    Z Hautkr; 1985 Sep; 60(18):1461-71. PubMed ID: 3933201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Gonococcus fights back: is this time a knock out?
    Lewis DA
    Sex Transm Infect; 2010 Nov; 86(6):415-21. PubMed ID: 20656721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic sensitivity of Neisseria gonorrhoeae isolates in Barbados: longitudinal surveillance 1990-1994.
    Levett PN
    West Indian Med J; 1995 Dec; 44(4):130-2. PubMed ID: 8838050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.
    Sutrisna A; Soebjakto O; Wignall FS; Kaul S; Limnios EA; Ray S; Nguyen NL; Tapsall JW
    Int J STD AIDS; 2006 Dec; 17(12):810-2. PubMed ID: 17212856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility pattern of Neisseria gonorrhoeae in western Austria.
    Allerberger F; Kofler H; Brezinka C; Guggenbichler JP; Dierich MP
    Wien Klin Wochenschr; 1993; 105(12):346-9. PubMed ID: 8333204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
    Ndowa F; Lusti-Narasimhan M; Unemo M
    Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629
    [No Abstract]   [Full Text] [Related]  

  • 33. The epidemiology of Neisseria gonorrhoeae in Europe.
    van Duynhoven YT
    Microbes Infect; 1999 May; 1(6):455-64. PubMed ID: 10602678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for the molecular detection of antibiotic resistance mechanisms in Neisseria gonorrhoeae.
    Goire N; Sloots TP; Nissen MD; Whiley DM
    Methods Mol Biol; 2012; 903():319-28. PubMed ID: 22782829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UK national guideline for the management of gonorrhoea in adults, 2011.
    Bignell C; Fitzgerald M; ;
    Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increase in the number of gonorrhea cases with increased antibiotic resistance in Amsterdam].
    Henquet CJ; Peerbooms PG; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1991 May; 135(21):950. PubMed ID: 1904994
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical treatment of sexually transmitted disease in developing countries I: Gonorrhoea.
    Osoba AO
    West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):50P-55P. PubMed ID: 139757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting core groups for gonorrhoea control: feasibility and impact.
    Giguère K; Alary M
    Sex Transm Infect; 2015 Jun; 91(4):241-4. PubMed ID: 25926404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity.
    Ndowa F; Lusti-Narasimhan M
    Reprod Health Matters; 2012 Dec; 20(40):76-82. PubMed ID: 23245412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of gonorrhea: current perspectives.
    Barnes RC; Holmes KK
    Epidemiol Rev; 1984; 6():1-30. PubMed ID: 6436045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.